Plain-English translation of NCT07095205 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This research explores how a chemical messenger in your brain called acetylcholine affects depression, and whether nicotine can help by boosting this system. Researchers will use special brain imaging scans before and after you wear nicotine patches for 8 days to see if the medication changes how your brain's communication chemicals work. The goal is to understand a new way to treat depression.
Current depression treatments don't work for everyone, and doctors want to explore new targets in the brain. This study investigates whether boosting acetylcholine — a brain chemical involved in mood and thinking — could be a new strategy to help people with depression feel better.
You likely qualify if…
You likely don't qualify if…
If you have depression, you will wear nicotine patches for 8 days and undergo two brain imaging scans using a special tracer — one before you start the patches and one after you finish. If you are in the comparison group (without depression), you will have one brain scan to help researchers understand what a healthy brain looks like. All visits take place at Stony Brook University, and the research team will monitor how you respond to the medication.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
United States